These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18193551)

  • 1. [Synthetic mineralocorticoid].
    Miyamori I
    Nihon Rinsho; 2008 Jan; 66(1):125-9. PubMed ID: 18193551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
    Wasniewska M; Valenzise M; Aversa T; Mirabelli S; De Luca F; De Luca FL; Lombardo F
    J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthetic mineralocorticoid, clinical application of fludrocortisone acetate (Florinef)].
    Igarashi Y
    Nihon Rinsho; 1994 Mar; 52(3):779-86. PubMed ID: 8164382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease.
    Tytherleigh MY; Vedhara K; Lightman SL
    Psychoneuroendocrinology; 2004 Jul; 29(6):712-23. PubMed ID: 15110920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
    Whitworth JA; Kelly JJ
    J Endocrinol Invest; 1995; 18(7):586-91. PubMed ID: 9221279
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludrocortisone induced heart failure in Addison's disease.
    Willis FR; Byrne GC; Jones TW
    J Paediatr Child Health; 1994 Jun; 30(3):280-1. PubMed ID: 8074919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.
    Nethathe GD; Lipman J; Anderson R; Fuller PJ; Feldman C
    Br J Anaesth; 2024 Jan; 132(1):53-65. PubMed ID: 38030548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with fludrocortisone in Addison's disease.
    Bhattacharyya A; Tymms DJ
    J R Soc Med; 1998 Aug; 91(8):433-4. PubMed ID: 9816363
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products.
    Bhargava A; Pearce D
    Trends Endocrinol Metab; 2004; 15(4):147-53. PubMed ID: 15109612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia.
    Kuhnle U; Land M; Ulick S
    J Clin Endocrinol Metab; 1986 May; 62(5):934-40. PubMed ID: 3007560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludrocortisone in the treatment of hypotensive disorders in the elderly.
    Hussain RM; McIntosh SJ; Lawson J; Kenny RA
    Heart; 1996 Dec; 76(6):507-9. PubMed ID: 9014799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
    Erbaş İM; Altincik SA; Çatli G; Ünüvar T; Özhan B; Abaci A; Anik A
    Turk J Med Sci; 2021 Feb; 51(1):231-237. PubMed ID: 33155789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping the pressure on mineralocorticoid replacement in congenital adrenal hyperplasia.
    Krone N; Webb EA; Hindmarsh PC
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):478-80. PubMed ID: 25510524
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypersensitivity to fludrocortisone acetate in a recipient of bone marrow transplantation.
    Kato J; Mori T; Kamo M; Tanikawa A; Iketani O; Okamoto S
    Allergol Int; 2011 Dec; 60(4):557-8. PubMed ID: 21681020
    [No Abstract]   [Full Text] [Related]  

  • 17. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Hochberg Z; Benderly A; Kahana L; Zadik Z
    J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effect of phenytoin on mineralocorticoid replacement with fludrocortisone in adrenal insufficiency.
    Keilholz U; Guthrie GP
    Am J Med Sci; 1986 Apr; 291(4):280-3. PubMed ID: 3706393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenogenital syndrome].
    Fujieda K
    Nihon Rinsho; 2006 Jun; Suppl 2():643-6. PubMed ID: 16817483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.